ABVC BIOPHARMA INC

NASDAQ: ABVC (ABVC Biopharma, Inc.)

Last update: 4 days ago, 10:37AM

1.48

0.27 (22.31%)

Previous Close 1.21
Open 1.26
Volume 465,072
Avg. Volume (3M) 410,929
Market Cap 24,824,484
Price / Sales 19.05
Price / Book 10.70
52 Weeks Range
0.400 (-72%) — 1.79 (20%)
Earnings Date 12 Aug 2025 - 18 Aug 2025
Operating Margin (TTM) -19,313.33%
Diluted EPS (TTM) -0.420
Quarterly Revenue Growth (YOY) -9.20%
Total Debt/Equity (MRQ) 441.35%
Current Ratio (MRQ) 0.330
Operating Cash Flow (TTM) -1.81 M
Levered Free Cash Flow (TTM) -2.07 M
Return on Assets (TTM) -38.38%
Return on Equity (TTM) -531.91%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Mixed Bearish
Biotechnology (Global) Mixed Bearish
Stock ABVC Biopharma, Inc. - -

AIStockmoo Score

0.4
Analyst Consensus 0.0
Insider Activity NA
Price Volatility -5.0
Technical Moving Averages 2.5
Technical Oscillators 4.0
Average 0.38

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
ABVC 25 M - - 10.70
ARWR 2 B - - 33.97
SPRY 1 B - - 5.32
VIR 603 M - - 0.660
REPL 560 M - - 1.12
RGLS 545 M - - 2.39

ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

Sector Healthcare
Industry Biotechnology
Investment Style Small Value
% Held by Insiders 18.05%
% Held by Institutions 3.20%

Ownership

Name Date Shares Held
Spotlight Asset Group, Inc. 30 Jun 2024 100

No data within this time range.

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria